Vivozon Pharmaceutical Co., Ltd. (KOSDAQ:082800)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,575.00
+105.00 (2.35%)
At close: Feb 6, 2026
-42.74%
Market Cap226.69B -40.1%
Revenue (ttm)66.40B -23.9%
Net Income-28.37B
EPS-566.79
Shares Out49.55M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume376,396
Average Volume1,003,895
Open4,385.00
Previous Close4,470.00
Day's Range4,290.00 - 4,650.00
52-Week Range3,685.00 - 9,520.00
Beta-0.64
RSI49.52
Earnings DateMar 20, 2026

About Vivozon Pharmaceutical

Vivozon Pharmaceutical Co., Ltd. researches, develops, produces, and sells LED products primarily in South Korea. The company offers LED packages for interior, general, indoor, decorative, and automotive lighting, as well as display applications. It also provides LED set linear lamps for offices, houses, apartments, buildings, factories, and parking lots. In addition, the company operates Echo House, a lighting show room that sells LED florescent lamps. The company was formerly known as Vivozon Healthcare, Inc. and changed its name to Vivozon P... [Read more]

Industry Pharmaceutical Preparations
Founded 2002
Employees 307
Stock Exchange KOSDAQ
Ticker Symbol 082800
Full Company Profile

Financial Performance

In 2024, Vivozon Pharmaceutical's revenue was 87.60 billion, an increase of 22.83% compared to the previous year's 71.32 billion. Losses were -9.98 billion, 197.3% more than in 2023.

Financial Statements